{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:45:08Z","timestamp":1791225908399,"version":"4.1.0"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Faculty of Medicine"},{"DOI":"10.13039\/501100003483","name":"Hebrew University of Jerusalem","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.jconrel.2018.12.050","type":"journal-article","created":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T16:45:48Z","timestamp":1546447548000},"page":"278-289","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Dispersible hydrolytically sensitive nanoparticles for nasal delivery of thyrotropin releasing hormone (TRH)"],"prefix":"10.1016","volume":"295","author":[{"given":"Moran Haim","family":"Zada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kubek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5365-9648","authenticated-orcid":false,"given":"Wahid","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Awanish","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Domb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2018.12.050_bb0005","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.yfrne.2010.01.001","article-title":"Regulation of the hypothalamic thyrotropin releasing rormone (TRH) neuron by neuronal and peripheral inputs","volume":"31","author":"Nillni","year":"2010","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0010","doi-asserted-by":"crossref","first-page":"T85","DOI":"10.1530\/JOE-15-0124","article-title":"60 years of neuroendocrinology: TRH, the first hypophysiotropic releasing hormone isolated: control of the pituitary\u2013thyroid axis","volume":"226","author":"Joseph-Bravo","year":"2015","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0015","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1210\/en.2008-1795","article-title":"Thyrotropin-releasing hormone and the thyroid hormone feedback mechanism","volume":"150","author":"Chiamolera","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.jconrel.2018.12.050_bb0020","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM198201213060305","article-title":"Thyrotropin-releasing hormone","volume":"306","author":"Jackson","year":"1982","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0025","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0165-0173(82)90012-1","article-title":"Regulatory peptides as a source of new drugs- the clinical prospects for analogues of TRH which are resistant to metabolic degradation","volume":"4","author":"Metcalf","year":"1982","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0030","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1042\/cs0730449","article-title":"Clinical applications of thyrotropin-releasing hormone","volume":"73","author":"Griffiths","year":"1987","journal-title":"Clin. Sci."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0035","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1146\/annurev.pa.26.040186.001523","article-title":"Pharmacology of thyrotropin-releasing hormone","volume":"26","author":"Horita","year":"1986","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0040","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/0278-5846(88)90075-9","article-title":"TRH: behavioral and endocrine effects in man","volume":"12","author":"Loosen","year":"1988","journal-title":"Progr. Neuro-Psychopharmacol. Biol. Psychiatr."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0045","series-title":"Thyrotropin-Releasing Hormone. Biomedical Significance","first-page":"1","volume":"553","year":"1989"},{"key":"10.1016\/j.jconrel.2018.12.050_bb0050","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0300-9084(88)90160-5","article-title":"Degradation and biological inactivation of thyrotropin-releasing hormone (TRH): regulation of the membrane-bound TRH-degrading enzyme from rat anterior pituitary by estrogens and thyroid hormones","volume":"70","author":"Bauer","year":"1988","journal-title":"Biochimie"},{"key":"10.1016\/j.jconrel.2018.12.050_bb0055","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1749-6632.1989.tb46647.x","article-title":"Inhibitors of TRH-degrading enzymes","volume":"553","author":"Wilk","year":"1989","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0060","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/1043-2760(94)00216-Q","article-title":"Inactivation of thyrotropin-releasing hormone (TRH) by the hormonally regulated TRH-degrading ectoenzyme","volume":"6","author":"Bauer","year":"1995","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0065","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/BF01646547","article-title":"Single-compartment model analysis of thyrotropin-releasing hormone kinetics in hyper- and hypothyroid patients","volume":"68","author":"Duntas","year":"1990","journal-title":"Klin. Wochenschr."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0070","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1172\/JCI107339","article-title":"Metabolism and excretion of exogenous thyrotropin-releasing hormone in humans","volume":"52","author":"Bassiri","year":"1973","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0075","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1677\/joe.0.1180511","article-title":"Intra- and extravascular turnover of thyrotropin releasing hormone in normal man","volume":"118","author":"Iversen","year":"1988","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0080","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0378-5173(90)90382-E","article-title":"Prodrugs of peptides. 7. Transdermal delivery of thyrotropinreleasing hormone (TRH) via prodrugs","volume":"66","author":"M\u00f8ss","year":"1990","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0085","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/jps.2600721231","article-title":"Buccal absorption of protirelin: an effective way to stimulate thyrotropin and prolactin","volume":"72","author":"Anders","year":"1983","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0090","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-2007-1018627","article-title":"Pernasal versus intravenous administration of TRH: effects on thyrotropin, prolactin, triiodothyronine, thyroxine and thyroglobulin in healthy subjects","volume":"15","author":"Schifgen","year":"1983","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0095","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF03350636","article-title":"Comparative study of intravenous, nasal, oral and buccal TRH administration among healthy subjects","volume":"8","author":"Schurr","year":"1985","journal-title":"J. Endocrinol. Investig."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0100","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1021\/bi00766a020","article-title":"Orientation restrictions of the peptide hormone, thyrotropin-releasing factor, due to intramolecular hydrogen bonding","volume":"11","author":"Grant","year":"1972","journal-title":"Biochemistry"},{"key":"10.1016\/j.jconrel.2018.12.050_bb0105","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/jps.2600750803","article-title":"Comparison between the lontophoretic and passive transport of thyrotropin releasing hormone across excised nude mouse skin","volume":"75","author":"Burnette","year":"1986","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0110","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1517\/17425247.5.10.1159","article-title":"From nose to brain: understanding transport capacity and transport rate of drugs","volume":"5","author":"Wu","year":"2008","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0115","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3390\/pharmaceutics10010034","article-title":"Surface-modified nanocarriers for nose-to-brain delivery: from bioadhesion to targeting","volume":"10","author":"Sonvico","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2018.12.050_bb0120","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3109\/10717544.2014.920431","article-title":"Nasal nanotechnology: revolution for efficient therapeutics delivery","volume":"23","author":"Kumar","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0125","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3109\/10717544.2013.838014","article-title":"Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting","volume":"21","author":"Mahajan","year":"2014","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0130","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1021\/acs.molpharmaceut.6b00586","article-title":"Brain targeting of temozolomide via the intranasal route using lipid-based nanoparticles: brain pharmacokinetic and scintigraphic analyses","volume":"13","author":"Khan","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0135","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.2174\/0929867321666140716103130","article-title":"Nose-to-brain drug delivery by nanoparticles in the treatment of neurological disorders","volume":"21","author":"Ong","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0140","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1517\/17425247.3.4.529","article-title":"Intravail\u2122: Highly effective intranasal delivery of peptide and protein drugs","volume":"3","author":"Magg","year":"2006","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0145","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/S1359-6446(02)02529-1","article-title":"Nasal drug delivery: new developments and strategies","volume":"7","author":"Illum","year":"2002","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2018.12.050_bb0150","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0168-3659(02)00363-2","article-title":"Nasal drug delivery\u2013possibilities, problems and solutions","volume":"87","author":"Illum","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2018.12.050_bb0155","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/JCP.0b013e3182a96e2b","article-title":"Inhaled thyrotropin-releasing hormone for treatment of neuropsychiatric disorders","volume":"34","author":"Lehrer","year":"2014","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0160","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1073\/pnas.93.1.427","article-title":"Neuroprotective strategy for Alzheimer disease: intranasal administration of a fat neuropeptide","volume":"93","author":"Gozes","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0165","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/mds.870100318","article-title":"Beneficial effect of intranasal Desmopmssin for nocturnal polyuria in Parkinson's disease","volume":"l0","author":"Suchowersky","year":"1995","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0170","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3109\/10717544.2013.838713","article-title":"Insights into direct nose to brain delivery: current status and future perspective","volume":"21","author":"Mittal","year":"2014","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0175","first-page":"29","article-title":"Neuropeptide thyroliberin--an endogenous anticonvulsant in the brain","volume":"33","author":"Chepurnov","year":"2002","journal-title":"Usp. Fiziol. Nauk"},{"key":"10.1016\/j.jconrel.2018.12.050_bb0180","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1111\/j.1528-1167.2007.01218.x","article-title":"Intranasal delivery of a thyrotropin-releasing hormone analog attenuates seizures in the amygdala-kindled rat","volume":"48","author":"Veronesi","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.jconrel.2018.12.050_bb0185","series-title":"Blood\u2013Brain Barrier: Drug Delivery and Brain Pathology","first-page":"323","article-title":"Issues related to intranasal delivery of neuropeptides to temporal lobe targets","author":"Kubek","year":"2001"},{"key":"10.1016\/j.jconrel.2018.12.050_bb0190","series-title":"Nanoparticles for Pharmaceutical Applications","first-page":"73","article-title":"Characterization of novel intranasal sustained-release nanoparticles for delivery of neuropeptides to the brain","author":"Kubek","year":"2007"},{"key":"10.1016\/j.jconrel.2018.12.050_bb0195","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.nurt.2009.02.001","article-title":"Attenuation of kindled seizures by intranasal delivery of neuropeptide-loaded nanoparticles","volume":"6","author":"Kubek","year":"2009","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jconrel.2018.12.050_bb0200","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.brainres.2009.09.039","article-title":"Thyrotropin-releasing hormone D,L polylactide nanoparticles (TRH-NPs) protect against glutamate toxicity in vitro and kindling development in vivo","volume":"1303","author":"Veronesi","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0205","series-title":"Novel Drug Delivery Systems","first-page":"139","article-title":"Nasal drug delivery systems","author":"Chien","year":"1992"},{"key":"10.1016\/j.jconrel.2018.12.050_bb0210","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/jps.20718","article-title":"Nanoparticulate systems for nasal delivery of drugs: a real improvement over simple systems?","volume":"96","author":"Illum","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0215","first-page":"333","article-title":"A Review on intranasal drug delivery system","volume":"3","author":"Appasaheb","year":"2013","journal-title":"J. Adv. Pharm. Edu. Res."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2007.03.025","article-title":"Intranasal delivery: physicochemical and therapeutic aspects","volume":"337","author":"Costantino","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0225","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.ijpharm.2014.10.059","article-title":"Administration strategies for proteins and peptides","volume":"477","author":"Ibraheem","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0230","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ijpharm.2009.06.019","article-title":"Nanoparticles for direct nose-to-brain delivery of drugs","volume":"379","author":"Mistry","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0235","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/polym10010031","article-title":"Polymer-based nanomaterials and applications for vaccines and drugs","volume":"10","author":"Han","year":"2018","journal-title":"Polymers"},{"key":"10.1016\/j.jconrel.2018.12.050_bb0240","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0006-8993(98)00860-9","article-title":"Prolonged seizure suppression by a single implantable polymeric-TRH microdisk preparation","volume":"809","author":"Kubek","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0245","first-page":"195","article-title":"Intranasal delivery of neuropeptide-loaded nanoparticles and their application to nervous system therapeutics","author":"Kubek","year":"2013","journal-title":"Focal Control. Drug Deliv."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0250","series-title":"Carrier-Based Drug Delivery, ACS Symposium Series","first-page":"267","article-title":"The cost of optimal drug delivery: reducing and preventing the burst effect in matrix systems","volume":"879","author":"Brazel","year":"2004"},{"key":"10.1016\/j.jconrel.2018.12.050_bb0255","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1021\/acs.chemrev.5b00346","article-title":"Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug release","volume":"116","author":"Kamaly","year":"2016","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0260","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/jbm.820200106","article-title":"Bioerodible polyanhydrides as drug-carrier matrices. II. Biocompatibility and chemical reactivity","volume":"20","author":"Leong","year":"1986","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0265","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0142-9612(95)93260-K","article-title":"In vivo and in vitro elimination of aliphatic polyanhydrides","volume":"16","author":"Domb","year":"1995","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2018.12.050_bb0270","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/0142-9612(94)90166-X","article-title":"Metabolic disposition and elimination studies of a radiolabeled biodegradable polymeric implant in the rat-brain","volume":"15","author":"Domb","year":"1994","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2018.12.050_bb0275","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0169-409X(02)00050-9","article-title":"Polyanhydrides: an overview","volume":"54","author":"Kumar","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0280","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1021\/ma00170a001","article-title":"Synthesis of polyanhydrides: melt-polycondensation, dehydrochlorination, and dehydrative coupling","volume":"20","author":"Leong","year":"1987","journal-title":"Macromolecules"},{"key":"10.1016\/j.jconrel.2018.12.050_bb0285","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s002890170029","article-title":"Preparation and properties of poly (dimer acid-sebacic acid) copolymer","volume":"46","author":"Xu","year":"2001","journal-title":"Polym. Bull."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0290","doi-asserted-by":"crossref","first-page":"5713","DOI":"10.1007\/s10853-009-3770-7","article-title":"A review on biodegradable polymeric materials for bone tissue engineering applications","volume":"44","author":"Sabir","year":"2009","journal-title":"J. Mater. Sci."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0295","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1002\/pola.1987.080251217","article-title":"Preparation of high molecular weight polyanhydrides","volume":"25","author":"Domb","year":"1987","journal-title":"J. Polym. Sci., Part A: Polym. Chem."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0300","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejps.2004.09.011","article-title":"Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles","volume":"24","author":"Bilati","year":"2005","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0305","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1023\/A:1016425826559","article-title":"High-performance liquid chromatographic assay for thyrotropin releasing hormone and benzyl alcohol in injectable formulation","volume":"4","author":"Rao","year":"1987","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0310","first-page":"015001","article-title":"Solvent-assisted in situ synthesis of cysteaminecapped silver nanoparticles, Adv","volume":"9","author":"Oliva","year":"2018","journal-title":"Nat. Sci."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0315","doi-asserted-by":"crossref","first-page":"1440002","DOI":"10.1142\/S1793984414400029","article-title":"Cytotoxicity of magnetic nanoparticles on normal and malignant human skin cells","volume":"4","author":"Amin","year":"2014","journal-title":"Nano LIFE"},{"key":"10.1016\/j.jconrel.2018.12.050_bb0320","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.tiv.2014.09.014","article-title":"Cell viability assessment using the Alamar blue assay: a comparison of 2D and 3D cell culture models","volume":"29","author":"Bonnier","year":"2015","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.jconrel.2018.12.050_bb0325","first-page":"10","article-title":"An overview of colorimetric assay methods used to assess survival or proliferation of mammalian cells","volume":"54","author":"Vega-Avila","year":"2011","journal-title":"Proc. West. Pharmacol. Soc."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0330","series-title":"Antibiotic and Cytotoxic Drug Susceptibility Assays Using Resazurin and Poising Agents, In, Google Patents","author":"Lancaster","year":"1996"},{"key":"10.1016\/j.jconrel.2018.12.050_bb0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/940585","article-title":"A review of indocyanine green fluorescent imaging in surgery","volume":"2012","author":"Alander","year":"2012","journal-title":"Int. J. Biomed. Imag."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0340","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jphotochem.2013.03.010","article-title":"Indocyanine green loaded biocompatible nanoparticles: Stabilization of indocyanine green (ICG) using biocompatible silica-poly(\u03b5-caprolactone) grafted nanocomposites","volume":"261","author":"Sch\u00f6nb\u00e4chler","year":"2013","journal-title":"J. Photochem. Photobiol. A Chem."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0345","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1002\/app.37708","article-title":"Preparation and characterization of biodegradable poly(sebacic anhydride) chain extended by glycol as drug carrier","volume":"127","author":"Liang","year":"2013","journal-title":"J. Appl. Polym. Sci."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0350","series-title":"Polymer Nanoparticles for Nanomedicines","year":"2016"},{"key":"10.1016\/j.jconrel.2018.12.050_bb0355","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0168-3659(01)00486-2","article-title":"Design of biodegradable particles for protein delivery","volume":"78","author":"Vila","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2018.12.050_bb0360","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ijpharm.2017.06.052","article-title":"Polymeric nanoparticles: Promising platform for drug delivery","volume":"528","author":"El-Say","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0365","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ijpharm.2008.12.015","article-title":"Intravesical cationic nanoparticles of chitosan and polycaprolactone for the delivery of Mitomycin C to bladder tumors","volume":"371","author":"Bilensoy","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0370","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0168-3659(98)00116-3","article-title":"PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug","volume":"57","author":"Govender","year":"1999","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2018.12.050_bb0375","first-page":"E16","article-title":"Improved entrapment efficiency of hydrophilic drug substance during nanoprecipitation of poly(l)lactide nanoparticles","volume":"5","author":"Peltonen","year":"2004","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2018.12.050_bb0380","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/1520-6017(200102)90:2<194::AID-JPS10>3.0.CO;2-Q","article-title":"Protein-fatty acid complex for enhanced loading and stability within biodegradable nanoparticles","volume":"90","author":"Yoo","year":"2001","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0385","doi-asserted-by":"crossref","first-page":"E594","DOI":"10.1208\/pt060474","article-title":"Nanoprecipitation versus emulsion-based techniques for the encapsulation of proteins into biodegradable nanoparticles and process-related stability issues","volume":"6","author":"Bilati","year":"2005","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2018.12.050_bb0390","doi-asserted-by":"crossref","first-page":"89","DOI":"10.14356\/kona.2018015","article-title":"Nanoparticle carrying biological molecules: recent advances and applications","volume":"35","author":"Saallah","year":"2018","journal-title":"KONA Powder Part. J."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0395","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejps.2004.09.011","article-title":"Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles","volume":"24","author":"Bilati","year":"2005","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0400","first-page":"1","article-title":"Preparation and characterization of water-soluble chitosan nanoparticles as protein delivery system","volume":"898910","author":"Zhang","year":"2010","journal-title":"J. Nanomater."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0405","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.3390\/ijms17122012","article-title":"Natural non-mulberry silk nanoparticles for potential-controlled drug release","volume":"17","author":"Wang","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0410","doi-asserted-by":"crossref","first-page":"24413","DOI":"10.1016\/S0021-9258(18)35782-X","article-title":"Thyrotropin-releasing hormone binding to the mouse pituitary receptor does not involve ionic interactions","volume":"267","author":"Perlman","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0415","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ejpb.2008.01.025","article-title":"How to concentrate nanoparticles and avoid aggregation?","volume":"69","author":"Vauthier","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0420","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s13204-015-0421-y","article-title":"Preparation and characterization of nanoparticles of carboxymethyl cellulose acetate butyrate containing acyclovir","volume":"6","author":"Vedula","year":"2016","journal-title":"Appl. Nanosci."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0430","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/1099-0488(20010315)39:6<703::AID-POLB1044>3.0.CO;2-B","article-title":"Laser light scattering study of the degradation of poly(sebacic anhydride) nanoparticles","volume":"39","author":"Fu","year":"2001","journal-title":"J. Polym. Sci. B Polym. Phys."},{"key":"10.1016\/j.jconrel.2018.12.050_bb0435","series-title":"Eukaryotic Cell Cultures: Basics and Applications","year":"1984"},{"key":"10.1016\/j.jconrel.2018.12.050_bb0440","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ijpharm.2004.03.032","article-title":"Indocyanine green-loaded biodegradable nanoparticles: preparation, physicochemical characterization and in vitro release","volume":"278","author":"Saxena","year":"2004","journal-title":"Int. J. Pharm."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365918307557?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365918307557?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T19:30:24Z","timestamp":1720899024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365918307557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":87,"alternative-id":["S0168365918307557"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2018.12.050","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dispersible hydrolytically sensitive nanoparticles for nasal delivery of thyrotropin releasing hormone (TRH)","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2018.12.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}